Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Mikus

Showing results (111-120 of 194) with videos related to

Pageof 20
Sort By:
British Journal of Clinical Pharmacology|April 22, 2010
Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patientsClaudia Sommerer, Sandra Müller-Krebs, Matthias Schaier, et al.
Clinical Pharmacokinetics|July 17, 2021
Perpetrator Characteristics of Azole Antifungal Drugs on Three Oral Factor Xa Inhibitors Administered as a Microdosed CocktailBrit Silja Rohr, Kathrin Isabelle Foerster, Antje Blank, et al.
The Journal of Antimicrobial Chemotherapy|May 4, 2016
Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humansNicolas Hohmann, Raphael Reinhard, Sven Schnaidt, et al.
Journal of Clinical Pharmacology|July 7, 2007
Renal safety and pharmacokinetics of ibandronate in multiple myeloma patients with or without impaired renal functionRaoul Bergner, Dirk M Henrich, Martin Hoffmann, et al.
Clinical and Translational Science|November 22, 2020
Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer using the CYP3A Inhibitor CobicistatNicolas Hohmann, Farastuk Bozorgmehr, Petros Christopoulos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2009
Efavirenz treatment and false-positive results in benzodiazepine screening testsAntje Blank, Victoria Hellstern, Dieter Schuster, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2010
No evidence for induction of ABC transporters in peripheral blood mononuclear cells in humans after 14 days of efavirenz treatmentJürgen Burhenne, Anne-Kathrin Matthée, Ivana Pasáková, et al.
Clinical Pharmacokinetics|November 9, 2004
Reduction of saquinavir exposure by coadministration of loperamide: a two-way pharmacokinetic interactionGerd Mikus, Laila Schmidt, Jürgen Burhenne, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2008
Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal functionTilman Heinrich, Hartmut Heidt, Verena Hafner, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 11, 2014
Lack of a clinically significant interaction of grapefruit juice with ambrisentan and bosentan in healthy adultsChristoph Markert, Theresia Wirsching, Regina Hellwig, et al.
Pageof 20

Showing results (111-120 of 194) with videos related to

Sort By:
Pageof 20
British Journal of Clinical Pharmacology|April 22, 2010
Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patientsClaudia Sommerer, Sandra Müller-Krebs, Matthias Schaier, et al.
Clinical Pharmacokinetics|July 17, 2021
Perpetrator Characteristics of Azole Antifungal Drugs on Three Oral Factor Xa Inhibitors Administered as a Microdosed CocktailBrit Silja Rohr, Kathrin Isabelle Foerster, Antje Blank, et al.
The Journal of Antimicrobial Chemotherapy|May 4, 2016
Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humansNicolas Hohmann, Raphael Reinhard, Sven Schnaidt, et al.
Journal of Clinical Pharmacology|July 7, 2007
Renal safety and pharmacokinetics of ibandronate in multiple myeloma patients with or without impaired renal functionRaoul Bergner, Dirk M Henrich, Martin Hoffmann, et al.
Clinical and Translational Science|November 22, 2020
Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer using the CYP3A Inhibitor CobicistatNicolas Hohmann, Farastuk Bozorgmehr, Petros Christopoulos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2009
Efavirenz treatment and false-positive results in benzodiazepine screening testsAntje Blank, Victoria Hellstern, Dieter Schuster, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2010
No evidence for induction of ABC transporters in peripheral blood mononuclear cells in humans after 14 days of efavirenz treatmentJürgen Burhenne, Anne-Kathrin Matthée, Ivana Pasáková, et al.
Clinical Pharmacokinetics|November 9, 2004
Reduction of saquinavir exposure by coadministration of loperamide: a two-way pharmacokinetic interactionGerd Mikus, Laila Schmidt, Jürgen Burhenne, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 5, 2008
Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal functionTilman Heinrich, Hartmut Heidt, Verena Hafner, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 11, 2014
Lack of a clinically significant interaction of grapefruit juice with ambrisentan and bosentan in healthy adultsChristoph Markert, Theresia Wirsching, Regina Hellwig, et al.
Pageof 20